v, A follow-up study was performed on 41 hydrocephalic children with primary (10 patients) or secondary (31 patients) placement of an anti-siphon device (ASD) connected to their shunt. The clinical course before and after ASD implantation was compared in these two groups, including studies of the head circumference, the radiological ventricular size, cerebrospinal fluid pressure studies on the supine and upright patient, and the history of shunt-induced complaints and complications leading to hospitalization. The authors discuss the pathophysiological concept of the "chronic overdrainage" or slit-ventricle syndrome based on ventricular collapse due to chronic suction-induced overdrainage by the vertical shunt system in the upright patient. The use of an ASD in connection with the regular shunt system of children with hydrocephalus is proposed. This ASD-shunt combination successfully reduced the number of complaints and shunt dysfunctions over a period of more than 6 years.
O
BSTRUCTION of the ventricular catheter with fibrin, neuroglia, or plexus tissue is still the most frequent complication of cerebrospinal fluid (CSF) shunts in pediatric hydrocephalus 4' 8' 11 ' 12 The failure of customarily used shunt systems to inhibit chronic CSF overdrainage when the patient is mobilized is, in our experience, the major cause of this complication. 6 We believed that the patient's well-being might improve and the complication rate might be diminished by safeguarding the shunt system with a suction-inhibiting anti-siphon device (ASD).* Therefore, in 1977, we began to use the ASD routinely in the management of pediatric hydrocephalus. The results of our experience are presented and discussed, comparing the clinical histories of our patients before and after the ASD implantation.
Clinical Material and Methods
Between 1977 and 1983, 41 children with congenital or acquired hydrocephalus of nontumor origin were treated with an ASD-shunt combination. Of these, 31 patients (Group A) had the ASD added to the normal *Anti-siphon device (ASD) manufactured by HeyerSchulte, Inc., P.O. Box 1386, Road 402 N, Anasco, Puerto Rico 00610.
shunt system during shunt revision or for treatment of a specific chronic overdrainage syndrome. Ten children (Group B) had an ASD-shunt combination inserted primarily. Group A patients were followed for 2 to 19 years (average 8 years) after the initial shunt insertion and again 3 to 7 years (average 3.7 years) after the ASD implantation. The follow-up period for Group B was 0.5 to 6 years (average 3.0 years).
The standard shunt system consisted of a parietooccipitally implanted ventricular catheter, a Rickham reservoir, a Holter-Spitz or Holter-Hausner valve, and a Holter atrial or Raimondi low-pressure peritoneal catheter. For the secondary ASD insertion the atrial shunt was usually replaced by a peritoneal shunt. The valve type was generally not changed ( Table 1) . The ASD was positioned after the valve at the skull base level. The indications for secondary ASD implantation in the 31 Group A patients were: acute ventricular catheter obstruction in 14 patients, recurrent overdrainage symptomatology with recurrent signs of transitory shunt dysfunction in eight patients, and a prophylactic implantation during the revision of a distal catheter obstruction or disconnection in nine patients (Fig. 1) .
This follow-up study compared the frequency of chronic recurrent complaints, shunt function, ventricular size, head circumference, CSF pressure of the mobilized patient, and the frequency of shunt dysfunctions tions leading to hospitalization were recorded chronologically, and classified as proximal or distal, mechanical, functional, or infectious ( Fig. 1 ).
Summary of Cases Group A: Secondary ASD Implantation
The follow-up results in both groups are given in Table 2 , and a clinical summary of Group A patients is presented in Table 3 .
Complaints. Before ASD implantation, 22 (71%) of the 31 children reported chronic recurrent complaints during the daytime or after unusual activity (weekend, vacation). Twelve (39%) of the patients who were hospitalized because of recurrent complaints recovered when at bedrest in a supine position. The occurrence of complaints was significantly reduced to two patients (6%) after ASD implantation.
Valve Function. All 31 patients without an ASD had an easily compressible valve pumping chamber. The refilling time in 23 cases (74%), however, was markedly delayed. After ASD implantation, all valves except two (6%) pumped promptly with no delayed filling time.
Ventricular Size. Evaluation of the ventricular size by CT scan was performed during a symptom-free period on 24 patients without ASD and 22 patients after ASD implantation. Before ASD implantation, four patients (17%) had an enlarged ventricular system (ventricular index larger than 0.2), five patients (20%) had a normal ventricular system (ventricular index between R. Gruber, P. Jenny and B. Herzog 0.1 and 0.2), and in 15 patients (63%) the ventricles had completely collapsed. In cases with asymmetrical ventricles, the side with the draining catheter was always smaller. After ASD insertion, only three ventricles (14%) remained slit-like, 11 (50%) were within normal limits, and eight (36%) showed a moderate symmetrical enlargement (average ventricular index 0.3).
Head Circumference. After ASD insertion, the head circumference of the 31 children generally remained within the Prader growth scale limit. The average percentile was 68% before and 66% after ASD implantation.
CSF Pressure Monitoring. The CSF pressure of 13 patients before ASD and 19 children after ASD implantation was monitored in both the supine and upright positions. Before ASD placement, 12 of the 13 patients developed a markedly negative CSF pressure when in the upright position. For example, in spite of a highpressure valve, one 176-cm boy had a negative CSF pressure of more than -20 cm HzO (Fig. 2) .
None of the 19 patients with secondary ASD placement showed a negative CSF pressure when in the upright position. When in the supine position, these patients recorded a generally higher CSF pressure (average 14 cm H20) than the patients without ASD (average 6 cm H20), with an upper limit of 22 cm H20.
Shunt
Complications. There were 124 shunt complications among the 31 patients before ASD implantation, leading to four hospitalizations per patient. The complications consisted of 59 (48%) proximal catheter 
Group B: Primary ASD Insertion
Nine of the 10 patients with a primary ASD-shunt combination were newborn. All had peritoneal drainage, two with low-pressure valves and eight with medium-pressure Holter-Hausner valves. The follow-up time was 6 months to 6 years (average 3.0 years). No revisions were necessary. Nine children are free of chronic recurrent complaints, their head circumference remains in their percentile, slightly above normal (average 98%), and the valves are functioning properly (Table 2) .
Six children had postoperative CT examination of their ventricles. Three ventricles remained moderately enlarged (ventricular index 0.4), two were reduced to normal, and one was slit-like. The child with the collapsed ventricles had a low-pressure Holter-Hausner shunt, and developed chronic recurrent headache, a slowly refilling valve, and a decrease of the head circumference from the 100th percentile to the 40th percentile 12 months after shunt insertion. It must be assumed that the ASD function was disturbed due to an incorrect, unusually low placement of the ASD in the soft tissue of the neck.
Discussion
The suction effect of a hanging shunt system in vitro as well as in vivo is well documented. 2'3'6'~6'~7'2~ The chronic overdrainage syndrome is a functional shunt problem in the upright patient. Because all diagnostic procedures (ventriculogram, CT, scintigram, infusion test, CSF pressure monitoring) are performed in a supine position, the possibility of identifying and recognizing the problem is reduced.
The pathogenic origin of a chronic overdrainage (or slit-ventricle) syndrome is the suction-induced collapse of the ventricular wall around the draining catheter causing an intermittent and ultimately irreversible obstruction of the shunt system. This results in recurrent and finally acute progressive elevated intracranial pressure (ICP). 7 During the emergency revision of the obstructed ventricular catheter, the insertion of a new catheter into the slit-like collapsed ventricle is difficult and a bilateral subtemporal craniectomy may be required. 1 The elevation of shunt resistance with a high-pressure valve as proposed by Salmon '9 may delay ventricular collapse but does not preclude it. 9'~~ The two children in our follow-up group without ASD, who were treated for overdrainage symptoms with high-pressure valves, were not protected against acute ventricular obstructions (Figs. 2 and 3) .
The ASD positioned after the valve at the skull base level inhibits chronic ventricular collapse by abolishing the suction effect of the hanging shunt system. The positive results of our series confirm this theory and correspond with the findings of others. 9'1~ The insertion of an ASD into the regular shunt significantly reduced the morbidity, especially the complication and proximal shunt obstruction rate, of our hydrocephalic children (Fig. 1) .
A residual enlargement of the ventricular system in 36% of the children after ASD implantation did not correspond with symptoms of an elevated ICP, or with a reduction of psychomotor and educational development. 5 The increased compliance of the enlarged ventricular system is regarded as a desirable protection against acute ICP changes.
We therefore do not consider asymptomatic ventricular enlargement a therapeutic failure, but a physiological reversal of a suction-induced pseudoexpansion of the brain tissue. The rounded, symmetrically enlarged ventricles resemble those seen in arrested hydrocephalus. Considering that there is no relationship between ventricular enlargement and psychomotor and educational development, ~3-t5 the question arises as to whether an asymptomatic residual hydrocephalus is physiologically more adequate than a "normalized" ventricular system. 5 On the basis of reduction of complaints and the necessity for shunt revisions, we recommend the ASDvalve combination for routine shunting in pediatric hydrocephalus therapy.
